# Fogarty Institute for Innovation

Fogarty Institute for Innovation is an other based in Sydney, Australia.

## Overview

- **Organization type:** other
- **Headquarters:** Sydney, Australia
- **Region:** Oceania
- **Address:** Sydney, Australia
- **Founded:** 2004
- **Assets under management:** Undisclosed
- **Website:** fogartyinstitute.com
- **LinkedIn:** https://www.linkedin.com/company/fogarty-innovation

## Regulatory record

- **Reports private funds:** No

## About

The Fogarty Institute for Innovation was established in 2004 by Dr. Thomas Fogarty, a cardiovascular surgeon who holds more than 170 patents, notably the Fogarty balloon catheter for embolectomy. Rather than acting as a conventional investment vehicle, the Institute functions as a nonprofit medical-device accelerator and early-stage incubator, providing funding, mentorship, and lab space to healthcare startups. The Institute backs companies across medical devices, digital health, and biotechnology, with a focus on cardiovascular, laparoscopic, and neuromodulation technologies. Known portfolio companies include TransMed7 (a developer of multi-function interventional tools) and PathMaker Neurosystems (which targets motor recovery after stroke), though a full portfolio list is not maintained on the public record. The Institute's model combines direct capital deployment with operational support, typically taking equity stakes in portfolio firms. The Fogarty Institute has been based in the San Francisco Bay Area (Mountain View, Palo Alto) since inception, with additional operational roots in Sydney, Australia. The team includes a small group of advisors and executives drawn from the medical-device industry. The Institute has incubated over 60 companies, though it does not publicly disclose a current AUM or total deployment figure. In 2023, the Institute announced a partnership with the Stanford Byers Center for Biodesign, formalizing a long-standing collaboration. The Institute's nonprofit structure distinguishes it from typical family offices or venture capital firms: profits from exits are reinvested into the Institute's incubation pipeline, not returned to external limited partners. This governance model allows the Institute to take patient, long-duration positions in early-stage medical technologies without the time constraints of a traditional fund vehicle.

## Sectors

- Digital Health
- Healthcare Services
- Medical Devices
- Biotechnology

## Offices

- Mountain View, United States
- Palo Alto, United States

## People

- Dr. Thomas Fogarty — Founder

## Questions

### Who runs investment decisions at the Fogarty Institute for Innovation?

Dr. Thomas Fogarty, the founder and a prolific medical-device inventor, oversees the Institute alongside a small team of advisors and executives drawn from the medical-device industry. The Institute does not publicly disclose a CIO or investment committee structure.

### How does the Fogarty Institute source proprietary deal flow?

The Institute generates deal flow primarily through Dr. Fogarty's network in cardiovascular surgery and medical-device development, as well as its partnership with Stanford Byers Center for Biodesign. It also accepts applications from early-stage healthcare startups through its website.

### What investment stages does the Fogarty Institute typically target?

The Institute supports early-stage healthcare startups, from seed to Series A, with a focus on proof-of-concept and early clinical-stage companies in medical devices, digital health, and biotechnology.

### Which sectors does the Fogarty Institute explicitly avoid?

The Institute primarily invests in medical-device and healthcare-technology companies. It does not publicly exclude any sectors, but its track record concentrates on cardiovascular, laparoscopic, and neuromodulation devices, with no known activity in software-only or non-healthcare sectors.

## Related profiles

- [America II Group](https://altss.com/profile/america-ii-group)
- [Grupa Netsprint sp. Z o. O.](https://altss.com/profile/grupa-netsprint-sp-z-o-o)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/fogarty-institute-for-innovation

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology